Peter S. Macdonald

The preload recruitable stroke work relationship as a measure of left ventricular contractile dysfunction in porcine cardiac allografts.

Lazaroid (U74389G)-supplemented cardioplegia: results of a double-blind, randomized, controlled trial in a porcine model of orthotopic heart transplantation.

The initial rate of troponin I release post-reperfusion reflects the effectiveness of myocardial protection during cardiac allograft preservation.

Functional evidence of reversible ischemic injury immediately after the sympathetic storm associated with experimental brain death.

Cardioprotection by cariporide after prolonged hypothermic storage of the isolated working rat heart.

Enhanced cardioprotection of the rat heart during hypothermic storage with combined Na+ - H+ exchange inhibition and ATP-dependent potassium channel activation.

Improved preservation of the rat heart with celsior solution supplemented with cariporide plus glyceryl trinitrate.

Improved poststorage cardiac function by poly (ADP-ribose) polymerase inhibition: role of phosphatidylinositol 3-kinase Akt pathway.

Reproducibility of adenosine stress cardiovascular magnetic resonance in multi-vessel symptomatic coronary artery disease.

A recombinant human neuregulin-1 peptide improves preservation of the rodent heart after prolonged hypothermic storage.

An intervention to promote physical activity and self-management in people with stable chronic heart failure The Home-Heart-Walk study: study protocol for a randomized controlled trial.

Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy.

Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: a placebo controlled crossover trial.

A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors.

Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence.

Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? trial.

Enhanced preservation of the rat heart after prolonged hypothermic ischemia with erythropoietin-supplemented Celsior solution.

Atrial fibrillation: stroke prevention in focus.

Worsening renal function in heart failure: the need for a consensus definition.

Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.

Cardio-protective signalling by glyceryl trinitrate and cariporide in a model of donor heart preservation.

Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.

Effect of exercise and pump speed modulation on invasive hemodynamics in patients with centrifugal continuous-flow left ventricular assist devices.

Combined angiotensin receptor/neprilysin inhibitors: a review of the new paradigm in the management of chronic heart failure.

Impact of left ventricular assist device speed adjustment on exercise tolerance and markers of wall stress.

Heart failure: a major management challenge with encouraging recent progress.

The Prevalence and Prognostic Significance of Frailty in Patients With Advanced Heart Failure Referred for Heart Transplantation.

Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses.

Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.

Improved heart function from older donors using pharmacologic conditioning strategies.

Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.

Multi-morbidity, frailty and self-care: important considerations in treatment with anticoagulation drugs. Outcomes of the AFASTER study.

Extracorporeal Membrane Oxygenation for Acute Cardiogenic Shock: How Do You Mend a Broken Heart?

Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation.

Longitudinal structural, functional, and cellular myocardial alterations with chronic centrifugal continuous-flow left ventricular assist device support.

Pathophysiological Trends During Withdrawal of Life Support: Implications for Organ Donation After Circulatory Death.

Estimation of left ventricular assist device pre-load using pump flow waveform analysis.

Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives.

Handle with care: A systematic review on frailty in cardiac care and its usefulness in heart transplantation.

Frailty assessment instruments in heart failure: A systematic review.

Empagliflozin in the management of diabetes mellitus after cardiac transplantationResearch Correspondenceretain-->.

Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation.

The Home-Heart-Walk study, a self-administered walk test on perceived physical functioning, and self-care behaviour in people with stable chronic heart failure: A randomized controlled trial.

Long distance heart transplantation: a tale of two cities.

Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.

Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review.

#Frailty: A snapshot Twitter report on frailty knowledge translation.

A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.

Valvular Regurgitation in a Biventricular Mock Circulatory Loop.

Functional recovery after dantrolene-supplementation of cold stored hearts using an ex vivo isolated working rat heart model.

Beat-to-beat detection of aortic valve opening in HeartWare left ventricular assist device patients.

The Perspectives of Health Care Professionals on Providing End of Life Care and Palliative Care for Patients With Chronic Heart Failure: An Integrative Review.

The use of hospital-based services by heart failure patients in the last year of life: a discussion paper.

Letter by Fung et al Regarding Article, "Frailty and Clinical Outcomes in Heart Failure: A Systematic Review and Meta-analysis".

Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta-Analysis.

Cyclosporine A as a Cardioprotective Agent During Donor Heart Retrieval, Storage, or Transportation: Benefits and Limitations.

Impact of Pump Speed on Hemodynamics With Exercise in Continuous Flow Ventricular Assist Device Patients.

Heart transplantation from donation-after-circulatory-death (DCD) donors: Back to the future-Evolving trends in heart transplantation from DCD donors.

Heart Transplantation With Donation After Circulatory Death.

Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients.

The donor heart and organ perfusion technology.

Evaluating the convergent and discriminant validity of three versions of the frailty phenotype in heart failure: results from the FRAME-HF study.

Nutraceuticals in Patients With Heart Failure: A Systematic Review.

Survival After an Acute Heart Failure Admission. Twelve-Month Outcomes From the NSW HF Snapshot Study.

Enhanced functional recovery of the heart donated after circulatory death determination with antemortem heparin.

COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).

Clinician Perspectives on the Design and Application of Wearable Cardiac Technologies for Older Adults: Qualitative Study.

The cardioprotective potential of the sodium-glucose cotransporter 2 inhibitor empagliflozin in donor heart preservation.

'Put on your own oxygen mask before helping others': mitigating health care worker risk from COVID-19.

Platelet activation after withdrawal of life support in donation after circulatory death donors.

SEVERE HYPERTRIGLYCERIDEMIA ASSOCIATED WITH EVEROLIMUS TREATMENT AFTER HEART TRANSPLANTATION.

The impact of frailty on mortality after heart transplantation.

Phenotyping of Stable Left Ventricular Assist Device Patients Using Noninvasive Pump Flow Responses to Acute Loading Transients.

Predicting 10-year mortality in older adults using VO2max, oxygen uptake efficiency slope and frailty class.

Heart transplantation following donation after circulatory death: Expanding the donor pool.

The Effect of Increasing Donor Age on Myocardial Ischemic Tolerance in a Rodent Model of Donation After Circulatory Death.

Frailty: A Dynamic Process in Aortic Stenosis?

Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.

Prevention and Reversal of Frailty in Heart Failure　- A Systematic Review.

Alarms and Their Outcomes in Left Ventricular Assist Device Patients.

Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support.

Clinician Estimates of Frailty Compared to Formal Frailty Assessment in Adults With Heart Failure: A Cross-Sectional Analysis.

Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation.

Heart Transplantation From DCD Donors in Australia: Lessons Learned From the First 74 Cases.

Comparison of six frailty instruments in adults with heart failure: a prospective cohort pilot study.

Cutting the Ice in Donor Heart Preservation.

Rapid triage and transition to telehealth for heart transplant patients in the COVID-19 pandemic setting.

Tricuspid Regurgitation After Heart Transplantation: The Cause or the Result of Graft Dysfunction?

The role of frailty in advanced HF and cardiac transplantation.

Metabolic Sequelae of Everolimus Treatment After Cardiac Transplant: A Hypothesis-Generating Study.

Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices.

Understanding Tricuspid Regurgitation Post Cardiac Transplantation; Why "Anatomical" and "Functional" Just Won't Cut It.

DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and Phenocopies.

Simultaneous Heart and Kidney Transplantation for LVAD-supported Patients With Chronic Kidney Disease?

Using pulsatility responses to breath-hold maneuvers to predict readmission rates in continuous-flow left ventricular assist device patients.

Heart Transplantation From DCD Donors Enters the Mainstream.

The Relationship Between Rehabilitation and Frailty in Advanced Heart or Lung Disease.

Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System.

Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients.

The search continues: investigating potential biomarkers to predict cardiac allograft function from donation after circulatory death donors.